Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

121.50EUR
28 Aug 2015
Change (% chg)

€-0.60 (-0.49%)
Prev Close
€122.10
Open
€122.50
Day's High
€122.65
Day's Low
€119.65
Volume
2,006,884
Avg. Vol
2,436,165
52-wk High
€146.45
52-wk Low
€96.83

BAYGn.DE

Chart for BAYGn.DE

About

Bayer AG is a German holding company active in the field of health care, nutrition and high-tech materials. It has three subgroups: HealthCare, involved in the research, development and production of health products for people and animals, CropScience, engaged in the crop protection and non-agricultural pest control, and... (more)

Overall

Beta: 0.99
Market Cap(Mil.): €100,474.20
Shares Outstanding(Mil.): 826.95
Dividend: 2.25
Yield (%): 1.85

Financials

  BAYGn.DE Industry Sector
P/E (TTM): 28.81 35.90 36.13
EPS (TTM): 4.22 -- --
ROI: 7.40 15.37 14.83
ROE: 16.71 15.94 15.69
Search Stocks

Bayer One-A-Day plaintiffs beat dismissal of heart, immunity claims

- A federal judge in California has ruled that plaintiffs accusing Bayer of falsely stating that One-A-Day supplements can boost heart health and immunity have provided enough proof to survive the company's second bid to dismiss those claims.

20 Aug 2015

BRIEF-Bayer says Covestro unit names CEO and CFO

* Says Covestro management board named: Patrick Thomas and Frank H. Lutz confirmed as ceo and cfo Further company coverage:

13 Aug 2015

Bayer's MaterialScience open to M&A: Handelsblatt

FRANKFURT - MaterialScience, Bayer's plastics division, which plans to list on the stock exchange soon, could consider acquisitions, especially in polyurethane-related business, its head told a German paper.

10 Aug 2015

Bayer's MaterialScience open to M&A -Handelsblatt

FRANKFURT, Aug 10 - MaterialScience, Bayer's plastics division, which plans to list on the stock exchange soon, could consider acquisitions, especially in polyurethane-related business, its head told a German paper.

10 Aug 2015

German stocks - Factors to watch on August 10

FRANKFURT/BERLIN, Aug 10 - The DAX top-30 index looked set to open 0.5 percent higher on Monday, according to premarket data from brokerage Lang & Schwarz at 0602 GMT.

10 Aug 2015

UPDATE 2-Regeneron raises Eylea sales forecast, shares at record

* Shares up 9.3 pct at $605.93 (Adds details, background, analyst and company comments; updates share)

04 Aug 2015

BRIEF-U.S. FDA approves Bayer's Finacea foam for rosacea

* FDA approves Bayer's Finacea (azelaic acid) foam for the topical treatment of the inflammatory papules and pustules of mild to moderate rosacea

31 Jul 2015

Bayer says MaterialScience draws positive investor feedback

FRANKFURT, July 29 - Bayer's Chief Executive Marijn Dekkers told analysts in a conference call that the MaterialScience division's top management, which is preparing for a separate listing, has recently met with potential investors and received positive feedback.

29 Jul 2015

Bayer profit boosted by eye drug, better plastics margins

FRANKFURT - German drugmaker Bayer saw underlying core earnings increase by one third in the second quarter, helped by a gain in prescriptions of new drugs such as eye drug Eylea and lower raw material costs at its plastics division.

29 Jul 2015

UPDATE 2-Bayer profit boosted by eye drug, better plastics margins

* Plans to separately list MaterialScience unit on track (Adds share price, analyst comment, details on eye drug)

29 Jul 2015

Earnings vs. Estimates

Search Stocks